A detailed history of Woodline Partners LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Woodline Partners LP holds 132,765 shares of VRTX stock, worth $53.8 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
132,765
Holding current value
$53.8 Million
% of portfolio
0.56%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $61.1 Million - $67.1 Million
132,765 New
132,765 $61.7 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $940,506 - $1.13 Million
2,742 New
2,742 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $17.5 Million - $21.8 Million
-74,671 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $6.45 Million - $7.6 Million
-29,109 Reduced 28.05%
74,671 $19.5 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $4.12 Million - $5.2 Million
23,293 Added 28.94%
103,780 $22.8 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $15.2 Million - $17 Million
-83,577 Reduced 50.94%
80,487 $14.6 Million
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $9.38 Million - $11.1 Million
-50,012 Reduced 23.36%
164,064 $33.1 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $44.3 Million - $51.7 Million
214,076 New
214,076 $46 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.